Search research articles
Contact Us
Filters
Showing results (71-80 of 120) with videos related to
Page
of 12
Sort By:
European Journal of Preventive Cardiology
|
July 22, 2017
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
Manuela Casula, Angela Pirillo, Giuseppe Danilo Norata, et al.
Current Opinion in Lipidology
|
October 3, 2019
Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation: the role of HDL
Fabrizia Bonacina, Angela Pirillo, Alberico L Catapano, et al.
Cells
|
May 5, 2021
HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
Fabrizia Bonacina, Angela Pirillo, Alberico L Catapano, et al.
Atherosclerosis
|
July 26, 2011
Emerging role of high density lipoproteins as a player in the immune system
Giuseppe Danilo Norata, Angela Pirillo, Enrico Ammirati, et al.
Cardiovascular Research
|
June 18, 2014
HDL in innate and adaptive immunity
Alberico Luigi Catapano, Angela Pirillo, Fabrizia Bonacina, et al.
Current Atherosclerosis Reports
|
June 4, 2014
HDL: to treat or not to treat?
Angela Pirillo, Gianpaolo Tibolla, Giuseppe Danilo Norata, et al.
Current Atherosclerosis Reports
|
February 16, 2018
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
Angela Pirillo, Fabrizia Bonacina, Giuseppe Danilo Norata, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2008
The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells
Angela Pirillo, Patrizia Uboldi, Chiara Bolego, et al.
Cardiovascular Research
|
May 26, 2007
Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux
Angela Pirillo, Patrizia Uboldi, Gianluca Pappalardo, et al.
Lipids
|
February 27, 2014
15-lipoxygenase-mediated modification of HDL3 impairs eNOS activation in human endothelial cells
Lucia Cutuli, Angela Pirillo, Patrizia Uboldi, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 120) with videos related to
Sort By:
Page
of 12
European Journal of Preventive Cardiology
|
July 22, 2017
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
Manuela Casula, Angela Pirillo, Giuseppe Danilo Norata, et al.
Current Opinion in Lipidology
|
October 3, 2019
Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation: the role of HDL
Fabrizia Bonacina, Angela Pirillo, Alberico L Catapano, et al.
Cells
|
May 5, 2021
HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
Fabrizia Bonacina, Angela Pirillo, Alberico L Catapano, et al.
Atherosclerosis
|
July 26, 2011
Emerging role of high density lipoproteins as a player in the immune system
Giuseppe Danilo Norata, Angela Pirillo, Enrico Ammirati, et al.
Cardiovascular Research
|
June 18, 2014
HDL in innate and adaptive immunity
Alberico Luigi Catapano, Angela Pirillo, Fabrizia Bonacina, et al.
Current Atherosclerosis Reports
|
June 4, 2014
HDL: to treat or not to treat?
Angela Pirillo, Gianpaolo Tibolla, Giuseppe Danilo Norata, et al.
Current Atherosclerosis Reports
|
February 16, 2018
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
Angela Pirillo, Fabrizia Bonacina, Giuseppe Danilo Norata, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2008
The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells
Angela Pirillo, Patrizia Uboldi, Chiara Bolego, et al.
Cardiovascular Research
|
May 26, 2007
Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux
Angela Pirillo, Patrizia Uboldi, Gianluca Pappalardo, et al.
Lipids
|
February 27, 2014
15-lipoxygenase-mediated modification of HDL3 impairs eNOS activation in human endothelial cells
Lucia Cutuli, Angela Pirillo, Patrizia Uboldi, et al.
Page
of 12